Skip to main content

Prognostic stratification of brain metastases from hepatocellular carcinoma

Journal of Neuro-Oncology volume 120, pages 209–214 (2014)Cite this article

Abstract

The aim of this study is to evaluate prognostic factors of brain metastases from hepatocellular carcinoma. Medical records of 95 patients who have been diagnosed of brain metastases from hepatocellular carcinoma between January 2000 and December 2011 were retrospectively reviewed. The median age at diagnosis of brain metastases is 56.1 years. Eighty-two patients were male. Median interval from diagnosis of hepatocellular carcinoma to brain metastases was 29.5 months. Eighty-eight patents had extracranial metastases, and the lung was the most frequent involved organ. Motor weakness was the most frequent presenting symptom (49.5 %). Intracranial hemorrhage was present in 71 patients (74.7 %). Brain metastases were treated with whole brain radiation therapy (WBRT) alone in 57 patients, radiosurgery alone in 18, surgery and WBRT in 6, surgery and radiosurgery in 3, surgery alone in 3, radiosurgery and WBRT in 2, and conservative management only in 6. Median overall survival was 3.0 months. Multivariate analysis showed ECOG performance status, Child-Pugh class, AFP level, number of brain lesions, and treatment modality were associated with survival (p < 0.05). When patients were stratified with four prognostic factors including ECOG performance status, Child-Pugh class, AFP level, and number of brain lesions, median survival time for patients with 0–1, 2, 3–4 risk factors were 5.8 months, 2.5 months and 0.6 months, respectively (p < 0.001). In conclusion, we can estimate the survival of patients by prognostic stratification, although overall prognosis of patients with brain metastases from hepatocellular carcinoma is poor.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90. doi:10.3322/caac.20107

    PubMed  Article  Google Scholar 

  2. Jung K-W, Won Y-J, Kong H-J, Oh C-M, Seo HG, Lee J-S (2013) Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 45:1–14

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  3. Tunc B, Filik L, Tezer-Filik I, Sahin B (2004) Brain metastasis of hepatocellular carcinoma: a case report and review of the literature. World J Gastroenterol 10:1688–1689

    PubMed  Google Scholar 

  4. Chang L, Chen YL, Kao MC (2004) Intracranial metastasis of hepatocellular carcinoma: review of 45 cases. Surg Neurol 62:172–177. doi:10.1016/j.surneu.2003.10.002

    PubMed  Article  Google Scholar 

  5. Rahbari NN, Mehrabi A, Mollberg NM, Muller SA, Koch M, Buchler MW, Weitz J (2011) Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg 253:453–469. doi:10.1097/SLA.0b013e31820d944f

    PubMed  Article  Google Scholar 

  6. Shao YY, Lu LC, Cheng AL, Hsu CH (2011) Increasing incidence of brain metastasis in patients with advanced hepatocellular carcinoma in the era of antiangiogenic targeted therapy. Oncologist 16:82–86. doi:10.1634/theoncologist.2010-0272

    PubMed  Article  PubMed Central  Google Scholar 

  7. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R (1997) Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745–751

    PubMed  Article  CAS  Google Scholar 

  8. Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W (2008) A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 70:510–514. doi:10.1016/j.ijrobp.2007.06.074

    PubMed  Article  Google Scholar 

  9. Sperduto CM, Watanabe Y, Mullan J, Hood T, Dyste G, Watts C, Bender GP, Sperduto P (2008) A validation study of a new prognostic index for patients with brain metastases: the graded prognostic assessment. J Neurosurg 109(Suppl):87–89. doi:10.3171/JNS/2008/109/12/S14

    PubMed  Google Scholar 

  10. Nieder C, Marienhagen K, Geinitz H, Molls M (2009) Validation of the graded prognostic assessment index for patients with brain metastases. Acta Oncol 48:457–459. doi:10.1080/02841860802342390

    PubMed  Article  Google Scholar 

  11. Golden DW, Lamborn KR, McDermott MW, Kunwar S, Wara WM, Nakamura JL, Sneed PK (2008) Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site. J Neurosurg 109:Suppl: 77–Suppl: 86. doi:10.3171/JNS/2008/109/12/S13

    PubMed  Article  Google Scholar 

  12. Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, Bhatt A, Jensen AW, Brown PD, Shih H, Kirkpatrick J, Schwer A, Gaspar LE, Fiveash JB, Chiang V, Knisely J, Sperduto CM, Mehta M (2010) Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 77:655–661. doi:10.1016/j.ijrobp.2009.08.025

    PubMed  Article  Google Scholar 

  13. Choi HJ, Cho BC, Sohn JH, Shin SJ, Kim SH, Kim JH, Yoo NC (2009) Brain metastases from hepatocellular carcinoma: prognostic factors and outcome: brain metastasis from HCC. J Neurooncol 91:307–313. doi:10.1007/s11060-008-9713-3

    PubMed  Article  Google Scholar 

  14. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494–500. doi:10.1056/NEJM199002223220802

    PubMed  Article  CAS  Google Scholar 

  15. Jiang XB, Ke C, Zhang GH, Zhang XH, Sai K, Chen ZP, Mou YG (2012) Brain metastases from hepatocellular carcinoma: clinical features and prognostic factors. BMC Cancer 12:49. doi:10.1186/1471-2407-12-49

    PubMed  Article  PubMed Central  Google Scholar 

  16. Han JH, Kim DG, Park JC, Chung HT, Paek SH, Chung YS (2010) Little response of cerebral metastasis from hepatocellular carcinoma to any treatments. J Korean Neurosurg Soc 47:325–331. doi:10.3340/jkns.2010.47.5.325

    PubMed  Article  PubMed Central  Google Scholar 

  17. Hsieh MJ, Lu CH, Tsai NW, Lui CC, Chuang YC, Huang CR, Chen SF, Chang CC, Chang HW, Chang WN (2009) Prediction, clinical characteristics and prognosis of intracerebral hemorrhage in hepatocellular carcinoma patients with intracerebral metastasis. J Clin Neurosci 16:394–398. doi:10.1016/j.jocn.2008.05.010

    PubMed  Article  Google Scholar 

  18. Uchino K, Tateishi R, Shiina S, Kanda M, Masuzaki R, Kondo Y, Goto T, Omata M, Yoshida H, Koike K (2011) Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors. Cancer 117:4475–4483. doi:10.1002/cncr.25960

    PubMed  Article  Google Scholar 

  19. Tsao MN, Rades D, Wirth A, Lo SS, Danielson BL, Gaspar LE, Sperduto PW, Vogelbaum MA, Radawski JD, Wang JZ, Gillin MT, Mohideen N, Hahn CA, Chang EL (2012) Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): an American society for radiation oncology evidence-based guideline. Pract Radiat Oncol 2:210–225. doi:10.1016/j.prro.2011.12.004

    Article  PubMed Central  Google Scholar 

  20. Khan AJ, Dicker AP (2013) On the merits and limitations of whole-brain radiation therapy. J Clin Oncol 31:11–13

    PubMed  Article  Google Scholar 

  21. Soffietti R, Kocher M, Abacioglu UM, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Mueller RP, Tridello G, Collette L, Bottomley A (2013) A European organisation for research and treatment of cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol 31:65–72. doi:10.1200/JCO.2011.41.0639

    PubMed  Article  Google Scholar 

Download references

Conflict of interest

None.

Author information

Affiliations

  1. Department of Radiation Oncology, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 110-744, Republic of Korea

    Kyung Su Kim, Kyubo Kim, Eui Kyu Chie & Sung W. Ha

  2. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea

    Yoon Jun Kim, Jung Hwan Yoon & Hyo-Suk Lee

  3. Institute of Radiation Medicine, Medical Research Center, Seoul National University, Seoul, Republic of Korea

    Eui Kyu Chie & Sung W. Ha

Authors
  1. Kyung Su Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kyubo Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eui Kyu Chie
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoon Jun Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jung Hwan Yoon
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hyo-Suk Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sung W. Ha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kyubo Kim.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kim, K.S., Kim, K., Chie, E.K. et al. Prognostic stratification of brain metastases from hepatocellular carcinoma. J Neurooncol 120, 209–214 (2014). https://doi.org/10.1007/s11060-014-1547-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-014-1547-6

Keywords

  • Hepatocellular carcinoma
  • Brain metastases
  • Prognostic factor